CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and γ-interferon production during intravenous methylprednisolone treatment of multiple sclerosis

Journal of Neurology

Volumn 243, Issue 6, 1996, Pages 475-481

  Crockard, A D ^a   Treacy, M T ^a   Droogan, A G ^a   Hawkins, S A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CD4 lymphocyte subsets; Methylprednisolone; Multiple sclerosis

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; METHYLPREDNISOLONE; PHYTOHEMAGGLUTININ; STEROID;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS;

EID: 0030014343     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00900503     Document Type: Article

References (41)

1. Akbar AN, Salmon M, Janossy G (1991) The synergy between naive and memory T cells during activation. Immunol Today 12: 184-188
2. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G (1993) The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178: 427-438
3. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329: 1764-1769
4. Beckman I, Shepherd K, Dimopoulos K, Ahern M, Firgaira F, Bradley J (1994) Differential expression and regulation of cytokine mRNAs in normal human CD45R T cell subsets. Cytokine 6: 116-123
5. Beverley P (1991) Immunological memory in T cells. Curr Opin Immunol 3: 355-360
6. Brajczewska-Fischer W, Iwinska B, Kruszewska J, Korlak J, Czlonkowska A (1989) Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing panencephalitis and exacerbation of multiple sclerosis. Acta Neurol Scand 80: 390-393
7. Bryne JA, Butler JL, Cooper MD (1988) Differential activation requirements for virgin and memory T cells. J Immunol 141: 3249-3257
8. + helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent postthymic differentiation. J Immunol 141: 1464-1470
9. Compston DAS, Milligan NM, Hughes PJ, Gibbs J, McBroom V, Morgan BP, Campbell AK (1987) A double blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis. 2. Laboratory results. J Neurol Neurosurg Psychiatry 50: 517-522
10. Crockard AD, Treacy MT, Droogan AG, McNeill TA, Hawkins SA (1995) Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis. Multiple Sclerosis 1: 20-24
11. Croft M, Bradley LM, Swain SL (1994) Naive versus memory CD4 T cell response to antigen. J Immunol 152: 2675-2685
12. Dufour A, Schmaggi A, La Mantia L, Eoli M, Nespolo A, Mitanese C (1994) High dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients. Int J Neurosci 75: 119-128
13. + low T cells (T suppressor-effectors) in multiple sclerosis cerebrospinal fluid are increased during high dose corticosteroid treatment. J Neuroimmunol 31: 221-228
14. Ferrer JM, Plaza A, Kreisler M, Diaz-Espada F (1992) Differential interleukin secretion by in vitro activated human CD45RA and CD45R0 CD4+ T cell subsets. Cell Immunol 141: 10-20
15. + subset by cells from patients with multiple sclerosis. Cell Immunol 133: 306-316
16. Frequin STFM, Lamers KJB, Barkhof F, Jongen PJH, Hommes OR (1993) T cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high dose intravenous methylprednisolone. Acta Neurol Scand 88: 80-86
17. Frequin STFM, Lamers KJB, Barkhof F, Borm GF, Hommes OR (1994) Follow-up study of MS patients treated with high-dose intravenous methylprednisolone. Acta Neurol Scand 90: 105-110
18. Gallo P, Chiusole M, Sanzari M, Sivieri S, Piccinno MG, Argentiero V, Rizzotti P, Tavolato B (1994) Effect of high dose steroid therapy in MS patients. Acta Neurol Scand 89: 95-101
19. + (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis. J Neuroimmunol 33: 97-102
20. Hirsch RL, Panitch HS, Johnson KP (1985) Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro. J Clin Immunol 5: 386-389
21. Kesselring J, Miller DH, MacManus DG, Johnson G, Milligan NM, Scolding N, Compston DAS, McDonald WI (1989) Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. J Neurol Neurosurg Psychiatry 52: 14-17
22. Kirk P, Compston DAS (1990) The effect of methylprednisolone on lymphocyte phenotype and function in patients with multiple sclerosis. J Neuroimmunol 26: 1-8
23. + human T cells following polyclonal activation. Scand J Immunol 32: 243-253
24. Mackay CR (1991) T cell-memory: the connection between function, phenotype and migration pathways. Immunol Today 12: 189-192
25. Merrill JE, Mohlstrom C, Uittenbogaart C, Kermani-Arab V, Ellison GW, Myers LW (1984) Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. J Immunol 133: 1931-1937
26. Miller DH, Thompson AJ, Morrissey SP, MacManus DG, Moore SG, Kendall BE, Moseley IF, McDonald WI (1992) High dose steroids in acute relapses of multiple sclerosis: MRI evidence for possible mechanisms of therapeutic effect. J Neurol Neurosurg Psychiatry 55: 450-453
27. Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF (1985) The isolation and characterisation of the human suppressor inducer T cell subset. J Imnumol 134: 1508-1515
28. Morimoto C, Hafler DA, Weiner HL, Letvin NL, Hagan M, Daley J, Schlossman SF (1987) Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. N Engl J Med 316: 67-72
29. + cells. Autoimmunity 14: 37-43
30. Papiha SS, Broddy J, Roberts DF, Bates D (1989) PHA-induced interferon in multiple sclerosis: association between gamma interferon and clinical and genetic variables. Acta Neurol Scand 80: 145-150
31. + lymphocytes in multiple sclerosis. J Neurol 239: 437-440
32. Poser CM, Paty DW, Scheinberg L, et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231
33. + T cell subsets in remitting-relapsing multiple sclerosis. Ann Neurol 24: 192-199
34. Salmaggi A, Baldetorp B, Milanese C, Nespolo C, Parma R, Sandberg-Wollheim M (1991) Analysis of peripheral blood phenotype and function during dexamethasone treatment of progressive multiple sclerosis. Acta Neurol Scand 84: 91-97
35. Sanders ME, Makgoba MW, Shaw S (1988) Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 9: 195-199
36. + T cells exhibit similar CD3/T cell receptor-mediated transmembrane signalling capacities but differ in response to co-stimulating signals. Eur J Immunol 24: 1391-1395
37. Selmaj K, Nowak Z, Tchorzewski H (1988) Interleukin 1 and interleukin 2 production by peripheral blood mononuclear cells in multiple sclerosis patients. J Neurol Sci 85: 67-76
38. Summers KL, O'Donnell JH, Hart DNJ (1994) Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis. Clin Exp Immunol 97: 39-44
39. Vervliet G, Carton H, Billiau A (1985) Interferon production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases. Clin Exp Immunol 59: 391-397
40. + lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases. J Neurol 238: 209-211
41. Zola H, Flego L, MacArdle PJ, Donohoe PJ, Ranford J, Roberton D (1992) The CD45RO (p180, UCHL1) marker: complexity of expression in peripheral blood. Cell Immunol 145: 175-186